Working… Menu

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03816553
Recruitment Status : Active, not recruiting
First Posted : January 25, 2019
Last Update Posted : November 27, 2020
Information provided by (Responsible Party):
Xin Huang, Sun Yat-sen University